Literature DB >> 16997047

Recurrent hyponatremia associated with citalopram and mirtazapine.

Nuket Bavbek1, Ayse Kargili, Ali Akcay, Arif Kaya.   

Abstract

Depression is a common problem in elderly patients and frequently is treated with antidepressants. We present the case of a 67-year-old depressed woman who began treatment with citalopram. Two months later, hyponatremia was diagnosed, most likely syndrome of inappropriate antidiuretic hormone secretion. After discontinuation of citalopram therapy, serum sodium concentrations normalized. Later, she began treatment with mirtazapine. Five months after initiating mirtazapine therapy, she developed symptomatic hyponatremia. After mirtazapine therapy was discontinued, serum sodium concentrations normalized. In this case, unlike those previously reported, hyponatremia recurred 5 months after switching from citalopram to mirtazapine, which is believed to be a safe antidepressant. In conclusion, patients older than 60 years should have baseline electrolyte measurements before starting therapy with an antidepressant, and these should be monitored not only in the first weeks of treatment, but throughout the full course.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16997047     DOI: 10.1053/j.ajkd.2006.07.011

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  5 in total

Review 1.  [Polypharmacy and falls in the Elderly].

Authors:  Ulrike Sommeregger; Bernhard Iglseder; Birgit Böhmdorfer; Ursula Benvenuti-Falger; Peter Dovjak; Monika Lechleitner; Ronald Otto; Regina E Roller; Markus Gosch
Journal:  Wien Med Wochenschr       Date:  2010-06

2.  Variation in the CYP2D6 gene is associated with a lower serum sodium concentration in patients on antidepressants.

Authors:  Sonja Kwadijk-de Gijsel; Monique J Bijl; Loes E Visser; Ron H N van Schaik; Albert Hofman; Arnold G Vulto; Teun van Gelder; Bruno H Ch Stricker
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

Review 3.  A consensus statement for safety monitoring guidelines of treatments for major depressive disorder.

Authors:  Seetal Dodd; Gin S Malhi; John Tiller; Isaac Schweitzer; Ian Hickie; Jon Paul Khoo; Darryl L Bassett; Bill Lyndon; Philip B Mitchell; Gordon Parker; Paul B Fitzgerald; Marc Udina; Ajeet Singh; Steven Moylan; Francesco Giorlando; Carolyn Doughty; Christopher G Davey; Michael Theodoros; Michael Berk
Journal:  Aust N Z J Psychiatry       Date:  2011-09       Impact factor: 5.744

Review 4.  Mirtazapine Risk of Hyponatremia and Syndrome of Inappropriate Antidiuretic Hormone Secretion in Adult and Elderly Patients: A Systematic Review.

Authors:  Alberto Moscona-Nissan; Juan Carlos López-Hernández; Ana P González-Morales
Journal:  Cureus       Date:  2021-12-30

5.  Mirtazapine-associated hyponatremia presenting as delirium.

Authors:  Abhishek Ghosh; Aditya Hegde; Sandeep Grover
Journal:  Indian J Pharmacol       Date:  2014 Jul-Aug       Impact factor: 1.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.